It uses a 16-week escalation ladder so tolerability can be reviewed before the 2.4 mg weekly research-target dose
Metformin, a first-line biguanide medication, reduces glucose production and improves insulin sensitivity, whilst semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), enhances insulin secretion and promotes significant weight loss
Enriched with Liposomal Glutathione, a highly absorbable antioxidant that reduces pigmentation and oxidative stress while being protected from digestive breakdown for faster, more effective results
Cleveland Clinic: Creatine Nutrients: Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis Nutrients: Creatine Supplementation Beyond Athletics: Benefits of Different Types of Creatine for Women, Vegans, and Clinical PopulationsA Narrative Review The Gut Health MD Mayo Clinic: Diarrhea: When to See a Doctor Mayo Clinic: Diarrhea Office of Dietary Supplements: Dietary Supplements for Exercise and Athletic Performance Cleveland Clinic: Is the Creatine Loading Phase Worth Doing? Lynn Grieger, RDN, CDCES Medical Reviewer Lynn Grieger is a registered dietitian-nutritionist, certified diabetes care and education specialist, certified personal trainer, and certified health and wellness coach